Early Access — free while we kick the tires
EdgarHawk

Kaplan Johanne

Chief Development Officer

Officer
1 filing analyzed · 1 company · Latest 2026-02-23

Companies

Company Buys Sells Direction
ProMIS Neurosciences Inc. PMN 1 0 Net buying

Activity

February 2026
medium
Buy
1,629 shares
$25,005
Significance 5/10

CDO Kaplan buys 1,629 shares of PMN at $15.35; holdings rise to 3,941 shares (+70.5%)

Chief Development Officer Johanne Kaplan purchased 1,629 shares at $15.35 on 2026-02-19, increasing her holdings by 70.5% to 3,941 shares total, representing a $25,005.15 commitment. The transaction occurred when the stock was -43.6% from its 52-week high of $28.00 but +67.4% over the prior 30 days and +99.2% over 90 days, suggesting material recent momentum. The company is operating with a net loss of $-11,580,126.00 and trades at a P/E of 143.55 despite an $849.7M market cap, indicating elevated valuation relative to negative earnings. The substantial buy by a C-suite officer at these valuations and after significant recent gains merits investor attention to understand the company's financial trajectory and insider perspective on near-term prospects.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access